BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szydłowska I, Grabowska M, Nawrocka-Rutkowska J, Kram A, Piasecka M, Starczewski A. Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids. J Clin Med 2021;10:3721. [PMID: 34442017 DOI: 10.3390/jcm10163721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li B, Yuan Z, Zhang Y, Li F, Huang L, Yang Z, Liu H, Liu Z. Exploring the role of uterine fibroids in promotion of cardiovascular diseases by diabetes exposure: Findings from national health and nutrition examination survey 1999-2006. Front Cardiovasc Med 2022;9:975920. [PMID: 36017104 DOI: 10.3389/fcvm.2022.975920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kolanska K, Sbeih M, Canlorbe G, Mekinian A, Varinot J, Capmas P, Koskas M, Aractingi S, Daraï E, Chabbert-Buffet N. Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human Endometrium. J Clin Med 2021;10:4442. [PMID: 34640460 DOI: 10.3390/jcm10194442] [Reference Citation Analysis]